(2S)-1-[[5-(3-methyl-2H-indazol-5-yl)-6-thiophen-3-yl-3-pyridinyl]oxy]-3-phenylpropan-2-amine
C26H24N4OS — CID 46226413
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2S)-1-[[5-(3-methyl-2H-indazol-5-yl)-6-thiophen-3-yl-3-pyridinyl]oxy]-3-phenylpropan-2-amine
(2S)-1-[[5-(3-methyl-2H-indazol-5-yl)-6-thiophen-3-yl-3-pyridinyl]oxy]-3-phenylpropan-2-amine (PubChem CID 46226413) has the molecular formula C26H24N4OS and a molecular weight of 440.57 g/mol. Its IUPAC name is (2S)-1-[[5-(3-methyl-2H-indazol-5-yl)-6-thiophen-3-yl-3-pyridinyl]oxy]-3-phenylpropan-2-amine.
Molecular Properties
| Compound Name | (2S)-1-[[5-(3-methyl-2H-indazol-5-yl)-6-thiophen-3-yl-3-pyridinyl]oxy]-3-phenylpropan-2-amine |
|---|---|
| PubChem CID | 46226413 |
| Molecular Formula | C26H24N4OS |
| Molecular Weight | 440.57 g/mol |
| Exact Mass | 440.17 |
| IUPAC Name | (2S)-1-[[5-(3-methyl-2H-indazol-5-yl)-6-thiophen-3-yl-3-pyridinyl]oxy]-3-phenylpropan-2-amine |
| SMILES | Cc1[nH]nc2ccc(-c3cc(OC[C@@H](N)Cc4ccccc4)cnc3-c3ccsc3)cc12 |
| InChI | InChI=1S/C26H24N4OS/c1-17-23-12-19(7-8-25(23)30-29-17)24-13-22(14-28-26(24)20-9-10-32-16-20)31-15-21(27)11-18-5-3-2-4-6-18/h2-10,12-14,16,21H,11,15,27H2,1H3,(H,29,30)/t21-/m0/s1 |
| InChIKey | VPHOSYHDFSVNET-NRFANRHFSA-N |
| XLogP | 5.61 |
| TPSA | 76.82 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 440.57 |
| LogP ≤ 5 | 5.61 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 46226413 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.